Preclinical evidence for mitochondrial DNA as a potential blood biomarker for chemotherapy-induced peripheral neuropathy

Chemotherapy-induced peripheral neuropathy (CIPN) is a serious dose-limiting side effect of several first-line chemotherapeutic agents including paclitaxel, oxaliplatin and bortezomib, for which no predictive marker is currently available. We have previously shown that mitochondrial dysfunction is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Trecarichi, Annalisa, Duggett, Natalie A., Granat, Lucy, Lo, Samantha, Malik, Afshan N., Zuliani-Álvarez, Lorena, Flatters, Sarah J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752024/
https://www.ncbi.nlm.nih.gov/pubmed/35015774
http://dx.doi.org/10.1371/journal.pone.0262544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752024/
https://www.ncbi.nlm.nih.gov/pubmed/35015774
http://dx.doi.org/10.1371/journal.pone.0262544

Ejemplares similares